27/07/2026
π ANTIVENOM CRISIS CONTINUES | POLYVALENT ANTIVENOM NOW DELAYED UNTIL 31 OCTOBER 2026 π¨
The South African Vaccine Producers (SAVP), a subsidiary of the National Health Laboratory Service (NHLS), has released a new stakeholder communication regarding antivenom availability, and unfortunately the situation has worsened.
According to the latest update released today:
β Polyvalent Antivenom β Out of Stock. Expected availability: 31 October 2026
β Spider Antivenom β Out of Stock. Expected availability: 31 October 2026
β
Boomslang Antivenom β Stock Available
β
Echis Antivenom β Stock Available
β
Scorpion Antivenom β Stock Available
This means South Africa is facing at least another three months without locally produced polyvalent antivenom, the primary antivenom used to treat severe envenomations from many of our most medically important snakes, including:
π Black Mamba
π Green Mamba
π Cape Cobra
π Forest Cobra
π Snouted Cobra
π Mozambique Spitting Cobra
π Black Spitting Cobra
π Rinkhals
π Puff Adder
π Gaboon Adder (where encountered)
β οΈ This should serve as a serious reminder to everyone working or living in snake-prone areas.
A severe bite from any species requiring polyvalent antivenom may now present an even greater challenge for healthcare providers due to the ongoing shortage.
It is important to note that Panafrican (PANAF) Polyvalent Antivenom has been shown to be an effective treatment option for many of the same medically important snake species treated with SAVP Polyvalent Antivenom. However, supplies of PANAF are limited in South Africa, meaning it cannot be relied upon as a guaranteed alternative during this shortage at all hospitals.
While some of the larger hospitals may still have stocks of SAVP or PANAF antivenom, availability varies considerably between facilities. Every effort should therefore be made to prevent snakebites, particularly over the coming months.
βοΈ Wear appropriate PPE when working in long grass, rocky areas, or bushveld.
βοΈ Never place your hands where you cannot see.
βοΈ Keep workplaces and homes clear of rubbish and rodent activity that attracts snakes.
βοΈ Ensure staff receive proper snake awareness and first aid training.
βοΈ Have an emergency response plan in place before an incident occurs.
βοΈ If a serious snakebite is suspected, seek emergency medical care immediately. Early supportive care, airway management, ventilation, and timely transport can be lifesaving, even when antivenom availability is limited.
We sincerely appreciate the continued efforts of the teams at SAVP and NHLS, who are working to restore production of these life-saving medicines. Manufacturing antivenom is a highly specialised process, and while these delays are frustrating, maintaining the highest quality and safety standards remains essential.
We will continue to share verified updates as they become available.